Genomic and Transcriptomic Determinants of Resistance to CDK4/6 Inhibitors and Response to Combined Exemestane plus Everolimus and Palbociclib in Patients with Metastatic Hormone Receptor Positive Breast Cancer
View ORCID ProfileJorge Gómez Tejeda Zañudo, Romualdo Barroso-Sousa, Esha Jain, Qingchun Jin, Tianyu Li, Jorge E. Buendia-Buendia, Alyssa Pereslete, Daniel L. Abravanel, Arlindo R. Ferreira, Eileen Wrabel, Karla Helvie, Melissa E. Hughes, Ann H. Partridge, Beth Overmoyer, Nancy U. Lin, Nabihah Tayob, Sara M. Tolaney, Nikhil Wagle
doi: https://doi.org/10.1101/2022.07.11.22277416
Jorge Gómez Tejeda Zañudo
1Cancer Program, Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
3Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
Romualdo Barroso-Sousa
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
3Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
4Oncology Center, Hospital Sírio-Libanês, Brasília, Brazil
Esha Jain
1Cancer Program, Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Qingchun Jin
5Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Tianyu Li
5Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Jorge E. Buendia-Buendia
1Cancer Program, Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Alyssa Pereslete
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Daniel L. Abravanel
1Cancer Program, Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
3Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
Arlindo R. Ferreira
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Eileen Wrabel
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Karla Helvie
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Melissa E. Hughes
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Ann H. Partridge
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
3Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
Beth Overmoyer
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
3Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
Nancy U. Lin
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
3Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
Nabihah Tayob
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
3Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
5Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Sara M. Tolaney
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
3Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
Nikhil Wagle
1Cancer Program, Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
3Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
Data Availability
Tumor and germline whole-exome sequencing data and RNA sequencing data generated and analyzed for this study are in the process of being deposited in dbGaP and will be available upon publication of the manuscript. Additional data generated in this study including clinical trial data, patient metadata, and tumor exome analysis are available in the Supplementary Data.
Posted July 12, 2022.
Genomic and Transcriptomic Determinants of Resistance to CDK4/6 Inhibitors and Response to Combined Exemestane plus Everolimus and Palbociclib in Patients with Metastatic Hormone Receptor Positive Breast Cancer
Jorge Gómez Tejeda Zañudo, Romualdo Barroso-Sousa, Esha Jain, Qingchun Jin, Tianyu Li, Jorge E. Buendia-Buendia, Alyssa Pereslete, Daniel L. Abravanel, Arlindo R. Ferreira, Eileen Wrabel, Karla Helvie, Melissa E. Hughes, Ann H. Partridge, Beth Overmoyer, Nancy U. Lin, Nabihah Tayob, Sara M. Tolaney, Nikhil Wagle
medRxiv 2022.07.11.22277416; doi: https://doi.org/10.1101/2022.07.11.22277416
Genomic and Transcriptomic Determinants of Resistance to CDK4/6 Inhibitors and Response to Combined Exemestane plus Everolimus and Palbociclib in Patients with Metastatic Hormone Receptor Positive Breast Cancer
Jorge Gómez Tejeda Zañudo, Romualdo Barroso-Sousa, Esha Jain, Qingchun Jin, Tianyu Li, Jorge E. Buendia-Buendia, Alyssa Pereslete, Daniel L. Abravanel, Arlindo R. Ferreira, Eileen Wrabel, Karla Helvie, Melissa E. Hughes, Ann H. Partridge, Beth Overmoyer, Nancy U. Lin, Nabihah Tayob, Sara M. Tolaney, Nikhil Wagle
medRxiv 2022.07.11.22277416; doi: https://doi.org/10.1101/2022.07.11.22277416
Subject Area
Subject Areas
- Addiction Medicine (353)
- Allergy and Immunology (675)
- Anesthesia (182)
- Cardiovascular Medicine (2675)
- Dermatology (226)
- Emergency Medicine (404)
- Epidemiology (12293)
- Forensic Medicine (10)
- Gastroenterology (768)
- Genetic and Genomic Medicine (4144)
- Geriatric Medicine (388)
- Health Economics (683)
- Health Informatics (2685)
- Health Policy (1008)
- Hematology (365)
- HIV/AIDS (857)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (443)
- Neurology (3927)
- Nursing (212)
- Nutrition (584)
- Oncology (2065)
- Ophthalmology (592)
- Orthopedics (243)
- Otolaryngology (306)
- Pain Medicine (251)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1126)
- Primary Care Research (461)
- Public and Global Health (6566)
- Radiology and Imaging (1415)
- Respiratory Medicine (874)
- Rheumatology (413)
- Sports Medicine (344)
- Surgery (454)
- Toxicology (54)
- Transplantation (189)
- Urology (169)